findmyKOL
Clinical trialNCT00546936UnknownPhase 2Interventional

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

SponsorBarnes Retina InstituteEnrollment30Presumed Ocular Histoplasmosis (POHS)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the change in visual activity of ranibizumab to Photodynamic Therapy (PDT)in patients with choroidal neovascularization (CNV) secondary to presumed ocular histoplasmosis
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Macula-Retina-Vitreous Service, Midwest Eye Institute

    Indianapolis, Indiana, United States

    Thomas Ciulla, MD
    Recruiting
  • Barnes Retina Institute

    St Louis, Missouri, United States

    Kevin J Blinder, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Ranibizumab →Verteporfin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2007
Primary completion
31 Oct 2009
Completion
30 Apr 2010
Last update posted
16 Apr 2009
Registered enrollment
30
Registry id
NCT00546936
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.